Rare disease research has long faced unique and persistent challenges. With small patient populations, geographic dispersion, and limited access to specialized research sites, traditional clinical trial models often fall short. However, the rise of decentralized clinical trials (DCTs) is transforming how rare disease studies are designed and conducted, making research more accessible,...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek